• Explore /
  • Poster
  • / Phase I trial of hyperthermic intraperitoneal chemoperfusion (HIPEC) with cisplatin, mitomycin, and paclitaxel in patients with gastric adenocarcinoma and carcinomatosis or positive cytology.

Phase I trial of hyperthermic intraperitoneal chemoperfusion (HIPEC) with cisplatin, mitomycin, and paclitaxel in patients with gastric adenocarcinoma and carcinomatosis or positive cytology.

Abstract Poster

Authors

null

Brian D. Badgwell

University of Texas MD Anderson Cancer Center, Houston, TX

Brian D. Badgwell , Mariela A. Blum , Naruhiko Ikoma , Xuemei Wang , Jeannelyn Estrella , Sinchita Roy-Chowdhuri , Prajnan Das , Bruce D. Minsky , Shumei Song , Paul F. Mansfield , Jaffer A. Ajani

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer

Clinical Trial Registration Number

NCT03330028

Citation

J Clin Oncol 37, 2019 (suppl; abstr 4056)

DOI

10.1200/JCO.2019.37.15_suppl.4056

Abstract #

4056

Poster Bd #

161

Abstract Disclosures

Similar Posters

First Author: Brian D. Badgwell

First Author: Ahmed Badran Sobh

First Author: Melissa Phillips

Poster

2016 ASCO Annual Meeting

Peritoneal mesothelioma: evaluation of chemotherapeutic agents used for HIPEC through the RENAPE database.

Peritoneal mesothelioma: evaluation of chemotherapeutic agents used for HIPEC through the RENAPE database.

First Author: Brice Malgras